Characterized Starting Materials for Accelerated and Scalable Allogeneic Cell Therapies
Time: 10:30 am
day: Day One
Details:
- Leveraging access to highly annotated diseased biomaterials for enhanced target discovery
- Outline how characterized donor source materials can impact consistency from process development to manufacturing
- Incorporating multiomic analytics of the cell-based starting materials to enhance downstream processing
